CareDx, Inc.: Form 10-K for the period ended Dec 31, 2016
Filed with the SEC on Apr 21, 2017 and accepted by EDGAR at Apr 21, 2017, 20:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-10-01 to 2016-12-31 | $10.9m | us-gaap:Revenues |
| Cost of revenue | 12 months2016-01-01 to 2016-12-31 | $10.2m | us-gaap:CostOfGoodsSold |
| Research and development | 12 months2016-01-01 to 2016-12-31 | $12.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2016-01-01 to 2016-12-31 | −$37.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2016-01-01 to 2016-12-31 | −$1.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-10-01 to 2016-12-31 | −$15.5m | us-gaap:NetIncomeLoss |
| Net income | 12 months2016-01-01 to 2016-12-31 | −$39.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-10-01 to 2016-12-31 | −$0.73 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | −$2.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-10-01 to 2016-12-31 | −$0.73 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2016-01-01 to 2016-12-31 | −$2.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-10-01 to 2016-12-31 | 21,270,151 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 12 months2016-01-01 to 2016-12-31 | 16,496,911 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 12 months2016-01-01 to 2016-12-31 | $549.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-12-31 | $17.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-12-31 | $26.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $76.7m | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $40.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-12-31 | $57.0m | us-gaap:Liabilities |
| Long-term debt | At period end2016-12-31 | $1.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-12-31 | $22.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2016-12-31 | $19.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001564590-17-006883. Last ingested by Listed: Nov 13, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.